Combining the power of nature and genomics to create new medicines

DemurisTM has a large portfolio of drug projects and state-of-the-art platform technologies in natural product discovery, design and production

The rise in drug resistant pathogens is causing serious health concerns and an increasing economic burden. There is a growing demand for new agents to treat these evolving diseases. Demuris is developing a suite of new antibiotic compounds active in key areas of unmet medical need.

The starting points for Demuris’ portfolio of new drug project portfolio lies in a unique collection of Actinomycete bacteria. These organisms specialise in making natural product (NP) compounds with powerful biological activities that kill or manipulate the behaviour of surrounding organisms, including bacteria, fungi, plants and animals.

Demuris is also developing advanced molecular biology and synthetic biology methods to identify new NPs, and manipulate them to make better drug-like molecules and at much higher yields.

Demuris can also offer its technology platform as a service for academics and companies wishing to discover and develop new drugs.

... only a fraction of the natural products that these bacteria are capable of making has been screened

LATEST NEWS

Vacancies at Demuris

Bioinformatic Research Scientist

Demuris is looking for a highly motivated Bioinformatician to support ongoing genome sequencing and antibiotic discovery programmes. The applicant will have demonstrable skills in computational biology / analysis of bacterial genomic data and experience in handling and processing larger scale next-generation sequencing (NGS) data.

Closing date for applications: 30 August 2019

Click here for full details.

Natural Product Chemist

Demuris is looking for a highly motivated natural product chemist to support its antibiotic discovery and development programmes.

Closing date for applications: 30 August 2019

Click here for full details.

Research Associate

Demuris is seeking to recruit a talented researcher in the area of actinomycete biology and natural product discovery. The post will be involved in the next generation sequencing of actinobacterial genomes and the discovery of new antibiotics from these bacteria.

Closing date for applications: 30 August 2019

Click here for full details.

Demuris Limited
The Biosphere, Draymans Way, Newcastle Helix,
Newcastle upon Tyne, NE4 5BX, UK

Tel: +44 (0)191 580 6177

Email: enquiries@demuris.co.uk

Demuris Limited is registered in England, company number: 06255507

Demuris Limited 2015